Patents by Inventor Wenhao Li

Wenhao Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzamides and related inhibitors of factor Xa
    Patent number: 7342013
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: March 11, 2008
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Patent number: 7285565
    Abstract: Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: October 23, 2007
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20070021472
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: July 17, 2006
    Publication date: January 25, 2007
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20060241153
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: May 26, 2006
    Publication date: October 26, 2006
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20060020039
    Abstract: Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: January 14, 2005
    Publication date: January 26, 2006
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20050261346
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: September 15, 2004
    Publication date: November 24, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert Scarborough
  • Benzamides and related inhibitors of factor Xa
    Patent number: 6844367
    Abstract: Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: January 18, 2005
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Patent number: 6835739
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: December 28, 2004
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20040097561
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: October 15, 2003
    Publication date: May 20, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Piperazin-2-one amides as inhibitors of factor xa
    Publication number: 20040072860
    Abstract: Novel piperazin-2-one containing compounds of general formulae (I) or (II), including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivative having activity against mammalian factor Xa arc described. Compositions containing such compounds are also described. The compounds and the compositions are useful in vitro or in vivo for preventing or treating conditions in mammals characterized by undesired thrombosis.
    Type: Application
    Filed: August 8, 2003
    Publication date: April 15, 2004
    Inventors: Bing-Yan Zhu, Ting Su, Wenhao Li, Erik A. Goldman, Penglie Zhang, Zhaozhong Jon Jia, Robert M. Sacrborough
  • Isoquinolone inhibitors of factor Xa
    Publication number: 20030186972
    Abstract: Novel compounds of formula I: 1
    Type: Application
    Filed: September 9, 2002
    Publication date: October 2, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Charles K. Marlowe, Wenhao Li, Ting Su, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20030162690
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described Compositions containing such compounds are also described The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders
    Type: Application
    Filed: April 22, 2002
    Publication date: August 28, 2003
    Applicant: COR Therapeutics, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Isoquinolone inhibitors of factor Xa
    Patent number: 6469026
    Abstract: Novel compounds of formula I: including its pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa is described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating conditions in mammals characterized by undesired thrombosis.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: October 22, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Charles K. Marlowe, Wenhao Li, Ting Su, Robert M. Scarborough
  • Isoquinolone inhibitors of factor Xa
    Publication number: 20020058677
    Abstract: Novel compounds of formula I: 1
    Type: Application
    Filed: March 26, 2001
    Publication date: May 16, 2002
    Inventors: Charles K. Marlowe, Wenhao Li, Ting Su, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Patent number: 6376515
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: April 23, 2002
    Assignee: COR Therapeutics, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert M. Scarborough
  • Bicyclic sulfonyl amino inhibitors of factor Xa
    Publication number: 20020019394
    Abstract: Novel compounds of formulae I or Ia: 1
    Type: Application
    Filed: March 26, 2001
    Publication date: February 14, 2002
    Inventors: Wenhao Li, Charles K. Marlowe, Robert M. Scarborough
  • Benzamides and related inhibitors of factor Xa
    Publication number: 20020002183
    Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: February 28, 2001
    Publication date: January 3, 2002
    Inventors: Bing-Yan Zhu, Penglie Zhang, Lingyan Wang, Wenrong Huang, Erick A. Goldman, Wenhao Li, Jingmei Zuckett, Yonghong Song, Robert Scarborough